Search research articles
Contact Us
Filters
Showing results (51-60 of 430) with videos related to
Page
of 43
Sort By:
Journal of Clinical Pathology
|
August 30, 2023
Should a borderline negative HER2 result in a core biopsy of invasive carcinoma of the breast have HER2 assessment repeated in the excision specimen?
Andrew H S Lee, Zsolt Hodi, Areeg Abbas, et al.
Histopathology
|
February 11, 2012
Concordance of HER2 status assessed on needle core biopsy and surgical specimens of invasive carcinoma of the breast
Andrew H S Lee, Heather P Key, Jane A Bell, et al.
Journal of Clinical Pathology
|
March 19, 2011
Breast carcinomas with borderline (2+) HER2 immunohistochemistry: percentage of cells with complete membrane staining for HER2 and the frequency of HER2 amplification
Andrew H S Lee, Heather P Key, Jane A Bell, et al.
Journal of Biomedical Informatics
|
January 24, 2012
Incorporation of expert variability into breast cancer treatment recommendation in designing clinical protocol guided fuzzy rule system models
Jonathan M Garibaldi, Shang-Ming Zhou, Xiao-Ying Wang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 29, 2010
Histological features of medullary carcinoma and prognosis in triple-negative basal-like carcinomas of the breast
Felicia Marginean, Emad A Rakha, Bernard C Ho, et al.
Human Pathology
|
November 11, 2003
An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast
Barbara Dunne, Andrew H S Lee, Sarah E Pinder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2004
Loss of CD55 is associated with aggressive breast tumors
Zahra Madjd, Lindy G Durrant, Richard Bradley, et al.
Breast Cancer Research and Treatment
|
February 23, 2008
Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications
Rabab A A Mohammed, Ian O Ellis, Somaia Elsheikh, et al.
Breast Cancer Research and Treatment
|
July 5, 2008
Tumor size is an unreliable predictor of prognosis in basal-like breast cancers and does not correlate closely with lymph node status
William D Foulkes, Matthew J Grainge, Emad A Rakha, et al.
Breast Cancer Research and Treatment
|
May 8, 2012
Fatty acid binding protein 7 expression and its sub-cellular localization in breast cancer
Alaa T Alshareeda, Emad A Rakha, Christopher C Nolan, et al.
Page
of 43
Search research articles
Search
Showing results (51-60 of 430) with videos related to
Sort By:
Page
of 43
Journal of Clinical Pathology
|
August 30, 2023
Should a borderline negative HER2 result in a core biopsy of invasive carcinoma of the breast have HER2 assessment repeated in the excision specimen?
Andrew H S Lee, Zsolt Hodi, Areeg Abbas, et al.
Histopathology
|
February 11, 2012
Concordance of HER2 status assessed on needle core biopsy and surgical specimens of invasive carcinoma of the breast
Andrew H S Lee, Heather P Key, Jane A Bell, et al.
Journal of Clinical Pathology
|
March 19, 2011
Breast carcinomas with borderline (2+) HER2 immunohistochemistry: percentage of cells with complete membrane staining for HER2 and the frequency of HER2 amplification
Andrew H S Lee, Heather P Key, Jane A Bell, et al.
Journal of Biomedical Informatics
|
January 24, 2012
Incorporation of expert variability into breast cancer treatment recommendation in designing clinical protocol guided fuzzy rule system models
Jonathan M Garibaldi, Shang-Ming Zhou, Xiao-Ying Wang, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
June 29, 2010
Histological features of medullary carcinoma and prognosis in triple-negative basal-like carcinomas of the breast
Felicia Marginean, Emad A Rakha, Bernard C Ho, et al.
Human Pathology
|
November 11, 2003
An immunohistochemical study of metaplastic spindle cell carcinoma, phyllodes tumor and fibromatosis of the breast
Barbara Dunne, Andrew H S Lee, Sarah E Pinder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2004
Loss of CD55 is associated with aggressive breast tumors
Zahra Madjd, Lindy G Durrant, Richard Bradley, et al.
Breast Cancer Research and Treatment
|
February 23, 2008
Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications
Rabab A A Mohammed, Ian O Ellis, Somaia Elsheikh, et al.
Breast Cancer Research and Treatment
|
July 5, 2008
Tumor size is an unreliable predictor of prognosis in basal-like breast cancers and does not correlate closely with lymph node status
William D Foulkes, Matthew J Grainge, Emad A Rakha, et al.
Breast Cancer Research and Treatment
|
May 8, 2012
Fatty acid binding protein 7 expression and its sub-cellular localization in breast cancer
Alaa T Alshareeda, Emad A Rakha, Christopher C Nolan, et al.
Page
of 43